181 related articles for article (PubMed ID: 37563671)
1. Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome.
Amin M; Horst N; Gragnoli C
J Ovarian Res; 2023 Aug; 16(1):158. PubMed ID: 37563671
[TBL] [Abstract][Full Text] [Related]
2. Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome.
Amin M; Horst N; Wu R; Gragnoli C
J Ovarian Res; 2023 Aug; 16(1):155. PubMed ID: 37543650
[TBL] [Abstract][Full Text] [Related]
3. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment.
Gómez R; Ferrero H; Delgado-Rosas F; Gaytan M; Morales C; Zimmermann RC; Simón C; Gaytan F; Pellicer A
J Clin Endocrinol Metab; 2011 Aug; 96(8):2484-92. PubMed ID: 21646367
[TBL] [Abstract][Full Text] [Related]
4. The melatonin receptor genes are linked and associated with the risk of polycystic ovary syndrome.
Postolache TT; Al Tinawi QM; Gragnoli C
J Ovarian Res; 2024 Jan; 17(1):17. PubMed ID: 38217063
[TBL] [Abstract][Full Text] [Related]
5. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome.
Amin M; Gragnoli C
J Ovarian Res; 2023 Nov; 16(1):222. PubMed ID: 37993904
[TBL] [Abstract][Full Text] [Related]
6. Novel linkage and association of TCF7L2 variants with PCOS in Italian families.
Amin M; Del Bosque-Plata L; Gragnoli C
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7346-7351. PubMed ID: 37606143
[TBL] [Abstract][Full Text] [Related]
7. Linkage and association of novel DRD2 variants to the comorbidity of type 2 diabetes and depression.
Amin M; Wu R; Postolache TT; Gragnoli C
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8370-8375. PubMed ID: 36459020
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide linkage and association study identifies novel genes and pathways implicated in polycystic ovarian syndrome.
Amin M; Gragnoli C
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3719-3732. PubMed ID: 37140321
[TBL] [Abstract][Full Text] [Related]
9. The glucocorticoid receptor gene (NR3C1) is linked to and associated with polycystic ovarian syndrome in Italian families.
Syed S; Gragnoli C
J Ovarian Res; 2024 Jan; 17(1):13. PubMed ID: 38217051
[TBL] [Abstract][Full Text] [Related]
10. The mineralocorticoid receptor gene (NR3C2) is linked to and associated with polycystic ovarian syndrome in Italian families.
Amin M; Perrelli M; Wu R; Gragnoli C
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):942-948. PubMed ID: 36808340
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin receptor (OXTR) is a risk gene for polycystic ovarian syndrome.
Amin M; Horst N; Wu R; Gragnoli C
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2634-2639. PubMed ID: 37013781
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
Li Q; Yan Z; Kuang Y; Zhou X; Jin L; He L; Sun X; Tao T; Wang L
Hum Reprod; 2016 Sep; 31(9):2150-7. PubMed ID: 27354380
[TBL] [Abstract][Full Text] [Related]
13. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome.
McCartney CR; Campbell RE; Marshall JC; Moenter SM
J Neuroendocrinol; 2022 May; 34(5):e13093. PubMed ID: 35083794
[TBL] [Abstract][Full Text] [Related]
14. Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.
Paoletti AM; Cagnacci A; Soldani R; Orrù M; Ajossa S; Pittorra G; Mulas P; Melis GB
Fertil Steril; 1995 Dec; 64(6):1094-8. PubMed ID: 7589658
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Determinants of Polycystic Ovary Syndrome.
Szeliga A; Rudnicka E; Maciejewska-Jeske M; Kucharski M; Kostrzak A; Hajbos M; Niwczyk O; Smolarczyk R; Meczekalski B
Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270780
[TBL] [Abstract][Full Text] [Related]
16. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS).
Garg A; Patel B; Abbara A; Dhillo WS
Clin Endocrinol (Oxf); 2022 Aug; 97(2):156-164. PubMed ID: 35262967
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in Pakistani women with polycystic ovary syndrome.
Liaqat I; Jahan N; Krikun G; Taylor HS
Reprod Sci; 2015 Mar; 22(3):347-57. PubMed ID: 25100445
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome.
Hernández I; Parra A; Méndez I; Cabrera V; Cravioto MC; Mercado M; Díaz-Sánchez V; Larrea F
Arch Med Res; 2000; 31(2):216-22. PubMed ID: 10880731
[TBL] [Abstract][Full Text] [Related]
19. Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.
Roland AV; Moenter SM
Front Neuroendocrinol; 2014 Oct; 35(4):494-511. PubMed ID: 24747343
[TBL] [Abstract][Full Text] [Related]
20. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
